ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Apellis Pharmaceuticals Inc

Apellis Pharmaceuticals Inc (APLS)

32.74
-1.26
(-3.71%)
Closed December 12 4:00PM
32.02
-0.72
(-2.20%)
After Hours: 6:55PM

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 22.66M44.85M94.97M110.4M146.38M172.33M199.68M196.83M
Operating Income -164.05M-175.08M-120.44M-137.08M-84.52M-62.09M-29.44M-47.28M
Pre Tax Income -167.46M-177.5M-121.84M-140M-84.15M-66.25M-37.54M-56.85M
Net Income -165.99M-177.78M-122.04M-140.24M-85.58M-66.42M-37.66M-57.45M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -164.3M-175.36M-120.51M-137.68M-84.3M-62.59M-29.42M-47.21M
EBITDA -163.67M-174.66M-120.02M-136.62M-84.04M-61.65M-29M-46.82M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 0000250.65M66.56M75.42M396.59M
Operating Income -27.28M-50.77M-127.93M-288.02M-213.73M-536.28M-594.61M-517.12M
Pre Tax Income -27.13M-51.01M-127.5M-304.71M-343.03M-746M-651.5M-523.5M
Net Income -27.13M-51.01M-127.5M-304.71M-344.87M-746.35M-652.17M-525.63M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -1.509-1.013-2.266-5.414-4.53-7.653-5.888-4.436
EBIT -27.13M-50.76M-128.04M-289.69M-214.23M-534.92M-594.9M-517.85M
EBITDA -27.28M-50.77M-127.93M-287.78M-213.09M-534.9M-593.06M-515.34M

Your Recent History

Delayed Upgrade Clock